Doorgaan naar hoofdcontent

Nurses: A Voice to Lead - A vision for future healthcare.

 

 
 
Nurses: A Voice to Lead - A vision for future healthcare.



 
 
Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Gastrointestinal Stromal Tumors,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR
Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Gastrointestinal Stromal Tumors,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Hypereosinophilic Syndrome, Date of authorisation: 07/11/2001, Revision: 41, Status: Authorised



 
 
Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/04/2005, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/04/2005, Revision: 28, Status: Authorised


Actueel zorgnieuws in jouw mailbox ontvangen?
Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.